Lundbeck increases its share capital by 6,574 shares (0.0033 % of outstanding shares) as a result of exercise of employee warrants
20 nov. 2018 05h51 HE
|
H. Lundbeck A/S
Valby, Nov. 20, 2018 (GLOBE NEWSWIRE) -- - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 32,870 as a consequence of the exercise of employee...
Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in 9M 2018. Guidance for FY2018 raised
07 nov. 2018 01h42 HE
|
H. Lundbeck A/S
Valby, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Financial report for the period 1 January to 30 September 2018 Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in...
Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia
25 oct. 2018 10h34 HE
|
H. Lundbeck A/S
Valby, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Corporate Release Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant...
Lundbeck opdaterer om klinisk fase III studie af Lu AF35700 til behandlingsresistent skizofreni
25 oct. 2018 10h34 HE
|
H. Lundbeck A/S
Valby, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Selskabsmeddelse Lundbeck opdaterer om klinisk fase III studie af Lu AF35700 til behandlings-resistent...
Takeda and Lundbeck submit New Drug Application (NDA) for vortioxetine in Japan for the treatment of Major Depressive Disorder (MDD)
28 sept. 2018 03h30 HE
|
H. Lundbeck A/S
Copenhagen, Sept. 28, 2018 (GLOBE NEWSWIRE) -- NDA submission highlights four key studies involving approximately 1,400 patients, including the pivotal phase III study conducted in JapanPivotal...
Takeda og Lundbeck indsender registreringsansøgning (NDA) for vortioxetin i Japan til behandling af depression
28 sept. 2018 03h30 HE
|
H. Lundbeck A/S
Copenhagen, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Registreringsansøgningen fremhæver fire nøglestudier, der omfatter cirka 1.400 patienter, herunder det pivotale fase III-studie udført i JapanDet...
Lundbeck realized 14% growth in revenue (local currencies) and 83% growth in EPS
08 août 2018 01h09 HE
|
H. Lundbeck A/S
Valby, Aug. 08, 2018 (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 9,288 million in the first six months of 2018 representing an increase of 9% (14% in local currencies) compared...
Dr. Deborah Dunsire bliver ny administrerende direktør for Lundbeck
02 juil. 2018 03h17 HE
|
H. Lundbeck A/S
Valby, Denmark, 2. juli 2018 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort, at bestyrelsen har udnævnt Dr. Deborah Dunsire som ny administrerende direktør for Lundbeck. Dr. Deborah Dunsire...
Dr. Deborah Dunsire named new President and CEO of Lundbeck
02 juil. 2018 03h17 HE
|
H. Lundbeck A/S
Valby, Denmark, 2 July 2018 - H. Lundbeck A/S (Lundbeck) today announced that the Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Dr. Dunsire...
Dr. Deborah Dunsire named new President and CEO of Lundbeck
02 juil. 2018 02h41 HE
|
H. Lundbeck A/S
Valby, Denmark, 2 July 2018 - H. Lundbeck A/S (Lundbeck) today announced that the Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Dr. Dunsire...